No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

George C. McFarland, MSW Joins Evon Medics, LLC as Advisor

Editor: What To Know

  • McFarland is a graduate of Leadership Maryland, a statewide leadership training Institute that brings together a collaboration of business leaders and practitioners to help solve problems unique to the state of Maryland.
  • McFarland’s network and experience working with numerous federal, state, and community organizations throughout the United States to improve the quality of life in communities affected by health and social determined risks would be valuable to Evon Medics as we continue to engage these underserved populations in our clinical trials,”.
  • McFarland has served on the Board of Directors for So Others Might Eat, a local homeless organization that provides shelter, food, education, and training to more than 13,000 residents of the District of Columbia annually.

George C. McFarland has joined the advisory board of Evon Medics, LLC in a formal advisory role.

Mr. McFarland is currently the President and CEO of McFarland & Associates, Inc. a management consulting firm established in Montgomery County, Maryland in 1989.

“Mr. McFarland’s network and experience working with numerous federal, state, and community organizations throughout the United States to improve the quality of life in communities affected by health and social determined risks would be valuable to Evon Medics as we continue to engage these underserved populations in our clinical trials,” said Charles Nwaokobia, Chief Operating Officer, Evon Medics, LLC. “We are also excited about the opportunity to leverage his wealth of experience managing over $100 million in grants and contracts to promote health and human development.”

George C. McFarland holds both BA and Master of Social Work degrees from Howard University with an emphasis on social policy, economics, and research. Over the past three decades McFarland & Associates, Inc. has served as both a prime contractor and subcontractor to many of the nation’s foremost research and service firms throughout the United States. He is a graduate of the United States Small Business Administration’s 8(a) Program designed to foster minority business ownership and growth.

McFarland is a graduate of Leadership Maryland, a statewide leadership training Institute that brings together a collaboration of business leaders and practitioners to help solve problems unique to the state of Maryland. For more than 25 years Mr. McFarland has served on the Board of Directors for So Others Might Eat, a local homeless organization that provides shelter, food, education, and training to more than 13,000 residents of the District of Columbia annually.

Evon Medics, LLC is a medical devices and neuroscience research company founded in April 2013 by Johns Hopkins trained physicians. The company develops therapeutics and devices for the treatment of Alzheimer’s Disease, Opioid Use Disorder, Traumatic Brain Injury, Chronic pain, and other chronic neurological diseases that have remained elusive to treatment. The company Head Office is in Elkridge, Maryland.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy